Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status

• Gillian Farnie ,

  * E-mail: gfarnie@picr.man.ac.uk

  Affiliation Cancer Stem Cell Research, University of Manchester, Institute of Cancer Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, The Christie NHS Foundation Trust, Manchester, United Kingdom

  ⨯
• Pamela M. Willan,

  Affiliation Cancer Stem Cell Research, University of Manchester, Institute of Cancer Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, The Christie NHS Foundation Trust, Manchester, United Kingdom

  ⨯
• Robert B. Clarke,

  Affiliation Breast Biology Group, University of Manchester, Institute of Cancer Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, The Christie NHS Foundation Trust, Manchester, United Kingdom

  ⨯
• Nigel J. Bundred

  Affiliation Academic Department of Surgery, University Hospital of South Manchester NHS Foundation Trust, Wythenshawe Hospital, Education and Research Centre, Manchester, United Kingdom

  ⨯